SRIT India's IPO carried a grey market premium (GMP) of Rs 31 on September 30, 2026, pointing to an estimated listing gain of 23.85%. Shah Investor's Home, which closed the same day, showed a GMP of Rs 15, or 8.98%. That 14.87 percentage-point gap is the clearest sentiment signal separating the two issues ahead of their October 6 listing.
Two IPOs, one listing day, very different signals
Both issues opened on September 28, closed on September 30, and are scheduled to list on NSE and BSE on October 6, 2026. The minimum retail ticket is close for both, at roughly Rs 14,000 to Rs 15,000. From there, the similarities end.
SRIT India is a Bengaluru-based IT and IT-enabled services (ITeS) company that builds and runs digital platforms for government health, e-governance and telecom clients. Shah Investor's Home, despite its name, is not a housing or real estate company. It is a Gujarat-based retail stockbroker founded in 1994.
The grey market has priced these two businesses very differently. Subscription data tells the same story: by the end of Day 2, SRIT India was subscribed 4.16 times against 1.10 times for Shah Investor's Home. This article explains what is driving the gap, what the numbers can and cannot tell you, and how different investor profiles might read each issue.
What is GMP, and how far can you trust it?
Grey market premium (GMP) is the extra amount traders are willing to pay for an IPO share before it lists on the stock exchange. If an IPO's upper price band is Rs 130 and the GMP is Rs 31, unofficial buyers are valuing the share at about Rs 161.
The estimated listing gain is calculated as:
Estimated listing gain (%) = (GMP ÷ Upper price band) × 100
For SRIT India, that works out to 31 ÷ 130 × 100 = 23.85%. For Shah Investor's Home, it is 15 ÷ 167 × 100 = 8.98%.
GMP is useful because it captures demand in real time. It moves with subscription figures, broader market mood and news flow, often faster than analyst notes do.
It also has hard limits that every investor should understand:
- It is unofficial. Grey market deals happen outside the exchange system. SEBI does not regulate them, and there is no published order book.
- It is thin. A small number of dealers can move the number. A Rs 5 swing can happen within hours.
- It can reverse. A weak market on listing day can wipe out the premium entirely, even for an oversubscribed issue.
Read GMP as a sentiment gauge, not a price forecast. It tells you how eager short-term traders are. It does not tell you what the business is worth.
SRIT India IPO: the growth case
SRIT India brings a Rs 218.40 crore IPO backed by rising revenue, rising profit, low debt and a large government order book. The grey market has rewarded that combination.
The business. SRIT has 26 years of operating history. It designs, implements and operates digital platforms for government bodies and enterprises, with three core verticals: healthcare, e-governance and telecom. Its health automation work covers more than 2,200 healthcare facilities, including state-level health information systems. The company reports an order book of Rs 1,204.7 crore, about 2.7 times its FY26 revenue.
The financials (FY26, year ended March 2026).
- Revenue from operations: about Rs 450 crore (Rs 4,500 million), up 15% year on year
- EBITDA: Rs 64.77 crore, a margin of 14.39%
- Profit after tax (PAT): Rs 43.29 crore, up 29%, a margin of 9.62%
- Net worth: Rs 193.27 crore, against borrowings of Rs 36.15 crore
EBITDA is earnings before interest, tax, depreciation and amortisation. It shows how much the core business earns before financing and accounting charges. PAT is the final profit left for shareholders.
The issue. The IPO is an entirely fresh issue of 1.68 crore shares at Rs 123 to Rs 130 each. One lot is 115 shares, so the minimum retail application is Rs 14,950. Of the net proceeds, Rs 124 crore goes to working capital and Rs 12.86 crore to capital expenditure. At the upper band, the post-issue market value is about Rs 835.5 crore, or roughly 19 times FY26 earnings.
The GMP signal. A Rs 31 premium implies a listing price near Rs 161, a potential gain of 23.85%. On one lot, that is about Rs 3,565 on paper.
Government-linked revenue gives SRIT multi-year visibility. It also brings a known trade-off: government clients often pay slowly, which is why Rs 124 crore of the proceeds is earmarked for working capital.
Shah Investor's Home IPO: a cyclical broker at a softer point
Shah Investor's Home is a Rs 90.17 crore issue from a profitable but shrinking broking business. The grey market is pricing a modest listing, not a weak one.
The business. Founded in 1994, the company offers equity and derivatives broking, IPO applications, mutual fund distribution and margin trading funding. It serves over one lakh demat accounts through 11 branches and 184 authorised persons, concentrated in Gujarat and Mumbai. Its fortunes track stock market trading volumes, not property prices.
The financials (FY26).
- Revenue: Rs 72.40 crore, down from Rs 94.46 crore in FY25
- EBITDA: Rs 21.61 crore, a margin of about 29.8%
- PAT: Rs 13.10 crore, down from Rs 23.41 crore, a margin of about 18.1%
- Return on net worth: 7.35%, down from 13.91%
The issue. It is a fresh issue of 53.99 lakh shares at Rs 159 to Rs 167. One lot is 85 shares, so the minimum retail application is Rs 14,195. Roughly two-thirds of the proceeds will fund working capital and expansion of its margin trading book. The market value at the upper band is about Rs 353 crore, or roughly 27 times FY26 earnings.
The GMP signal. A Rs 15 premium implies a listing price near Rs 182, a potential gain of 8.98%. On one lot, that is about Rs 1,275 on paper. Listing is expected on October 6, 2026.
Brokerage opinions were split. Swastika Investmart rated it Avoid, Religare and Ventura rated it Neutral, and BP Equities rated it Subscribe. Concerns cited include falling earnings, negative operating cash flow and regional concentration.
SRIT India vs Shah Investor's Home: head-to-head
| Metric | SRIT India | Shah Investor's Home |
|---|---|---|
| Business | IT/ITeS, e-governance, health tech, telecom | Retail stockbroking and allied services |
| Issue size | Rs 218.40 crore (fresh) | Rs 90.17 crore (fresh) |
| Shares offered | 1.68 crore | 53.99 lakh |
| Price band | Rs 123–130 | Rs 159–167 |
| Lot size | 115 shares | 85 shares |
| Minimum retail investment | Rs 14,950 | Rs 14,195 |
| GMP (Sept 30, 2026) | Rs 31 | Rs 15 |
| Estimated listing price | Rs 161 | Rs 182 |
| Estimated listing gain | 23.85% | 8.98% |
| Paper gain per lot | about Rs 3,565 | about Rs 1,275 |
| FY26 revenue | about Rs 450 crore (+15%) | Rs 72.40 crore (−23%) |
| FY26 PAT | Rs 43.29 crore (+29%) | Rs 13.10 crore (−44%) |
| EBITDA margin | 14.39% | about 29.8% |
| PAT margin | 9.62% | about 18.1% |
| Price-to-earnings (approx.) | about 19x | about 27x |
| Subscription (end of Day 2) | 4.16x | 1.10x |
| Retail subscription (Day 2) | 6.04x | 0.91x |
| Subscription window | Sept 28–30 | Sept 28–30 |
| Allotment | Oct 1 | Oct 1 |
| Listing | Oct 6, NSE and BSE | Oct 6, NSE and BSE |
GMP-based figures are estimates as of September 30, 2026, and will change. Growth rates are year on year versus FY25. P/E multiples are approximate, based on FY26 profit and the upper price band.
GMP-based figures are estimates as of September 30, 2026, and will change. Growth rates are year on year versus FY25. Price-to-earnings multiples are approximate, based on FY26 profit and the upper price band.
Why SRIT India's GMP is 14.87 points higher
The gap is driven by earnings direction and valuation, not by margins. On margins alone, Shah Investor's Home actually looks stronger. Four factors explain why the market still prefers SRIT India.
- Growth versus contraction. SRIT grew profit 29% in FY26. Shah's profit fell 44%. IPO buyers pay for the next three years, and one earnings line is rising while the other is falling.
- Cheaper entry for a growing business. SRIT is priced at about 19 times earnings; Shah at about 27 times. A growing company at a lower multiple leaves more room for a listing-day re-rating.
- Revenue visibility. SRIT's Rs 1,204.7 crore order book covers roughly 2.7 years of current revenue. Much of it comes from state health and e-governance programmes, which run on multi-year contracts. Broking revenue has no such backlog. It resets every month with market volumes.
- Sector cycle. Digital public infrastructure spending in India is a long-term policy priority. Retail broking, by contrast, is highly sensitive to market sentiment and to regulation. Tighter SEBI rules on futures and options trading since late 2024 have weighed on volumes across the sector, and Shah's FY26 numbers reflect that.
Subscription confirms the read. Retail investors bid for SRIT 6.04 times on Day 2 but did not fully subscribe Shah's retail portion (0.91 times).
For experienced investors, one caution. SRIT's qualified institutional buyer (QIB) book was only about 3% subscribed on Day 2. Institutions often bid on the final day, so check the closing QIB figure before reading too much into retail enthusiasm.
Learn to read IPOs before you apply
Want to evaluate the next IPO on your own, not just follow the grey market?
ICFM India trains investors and traders to read a draft prospectus, compare valuations against listed peers, interpret subscription data and set a listing-day plan with clear exit rules.
Programmes run in classroom batches at Laxmi Nagar, Delhi, and online, and cover everything from market basics to derivatives and algorithmic trading.
Book a free counselling session with ICFM India to find the course that fits your experience level and goals.
ICFM India provides market education and training. It does not provide stock tips or personalised investment advice.
Risk factors to weigh
Neither listing gain is assured. Before applying, or before deciding what to do on listing day, weigh these risks.
Common to both
- GMP is unofficial and unregulated. It can fall sharply between allotment on October 1 and listing on October 6.
- A heavily oversubscribed issue lowers your chance of allotment. Retail allotment is usually by lottery, one lot per successful applicant.
- A broad market sell-off in the listing week can override company-level sentiment.
SRIT India
- High dependence on government clients, which concentrates revenue and exposes it to changes in state budgets or policy.
- Long receivable cycles. Brokerages including Swastika Investmart flagged working capital management as the key variable.
- IT services pricing pressure and execution risk on large, fixed-scope public projects.
Shah Investor's Home
- Earnings fell sharply in FY26, and a recovery depends on trading volumes returning.
- Regulatory changes to derivatives trading directly affect broking income.
- Margin trading funding adds credit risk: if clients default in a falling market, the broker absorbs losses.
- Geographic concentration in Gujarat and Mumbai.
Suitability. Listing-gain applicants should be comfortable with a possible loss on day one. Long-term investors should judge each business on its prospectus, not its GMP.
Key takeaways
- SRIT India shows the stronger grey market signal: a Rs 31 GMP implies a 23.85% listing gain, against 8.98% for Shah Investor's Home, a gap of 14.87 percentage points.
- Growth drives the gap: SRIT's FY26 profit rose 29% while Shah's fell 44%.
- Margins favour Shah, valuation favours SRIT: Shah earns higher margins (about 18% PAT versus 9.62%), but SRIT is priced lower at about 19 times earnings versus about 27 times.
- Demand is broader for SRIT: 4.16 times overall and 6.04 times retail subscription by Day 2, versus 1.10 times and 0.91 times for Shah.
- Shah Investor's Home is a stockbroker, not a real estate firm: its results move with market trading volumes and SEBI rules.
- Entry cost is similar: Rs 14,950 for one SRIT lot and Rs 14,195 for one Shah lot.
- Both list on October 6, 2026 on NSE and BSE, with allotment on October 1.
- For HNIs: watch SRIT's final QIB subscription and its receivable days. For Shah, the case rests on a breaking-volume recovery.
Frequently asked questions
1. What is GMP, and how reliable is it as a listing price predictor?
Grey market premium (GMP) is the unofficial premium traders pay for IPO shares before they list. It is quoted in rupees above the upper price band. SRIT India's GMP of Rs 31 on a Rs 130 band implies an estimated listing price of Rs 161. GMP is a reasonable gauge of short-term demand and usually tracks subscription figures. It is not a reliable price predictor. The grey market is unregulated, thinly traded and prone to sudden swings. Actual listing prices regularly land above or below GMP estimates, especially when the broader market turns between allotment and listing.
2. Why does SRIT India have a higher GMP than Shah Investor's Home?
SRIT India's GMP of Rs 31 (23.85%) is higher than Shah Investor's Home's Rs 15 (8.98%) mainly because of earnings direction. SRIT's FY26 revenue grew 15% to about Rs 450 crore, and its profit after tax rose 29% to Rs 43.29 crore. Shah's profit fell 44% to Rs 13.10 crore. SRIT also has a Rs 1,204.7 crore order book from government health and e-governance projects, which gives revenue visibility. At about 19 times earnings, it is priced lower than Shah at about 27 times. Stronger subscription, 4.16 times against 1.10 times by Day 2, reinforces the premium.
3. Which IPO has higher listing gain potential, and why?
Based on GMP data as of September 30, 2026, SRIT India has the higher listing gain potential. Its estimated listing price is Rs 161, a 23.85% gain over the Rs 130 upper band. Shah Investor's Home's estimated listing price is Rs 182, an 8.98% gain over its Rs 167 band. The difference is 14.87 percentage points. In rupee terms, one SRIT lot of 115 shares shows a paper gain of about Rs 3,565, against about Rs 1,275 for one Shah lot of 85 shares. These are estimates only. The actual listing price is set by exchange demand on October 6.
4. What is the minimum investment for each IPO?
The minimum retail investment is Rs 14,950 for SRIT India and Rs 14,195 for Shah Investor's Home. A lot is the smallest block of shares you can apply for. SRIT's lot is 115 shares at the Rs 130 upper band; Shah's lot is 85 shares at the Rs 167 upper band. Retail individual investors, defined by SEBI as those applying for up to Rs 2 lakh, can bid for multiple lots within that limit. Bidding at the cut-off price means you accept whatever final price is fixed within the band, which keeps your application valid if the issue prices at the upper end.
5. When do SRIT India and Shah Investor's Home list?
Both IPOs are scheduled to list on NSE and BSE on Tuesday, October 6, 2026. The subscription window for both ran from September 28 to September 30. Share allotment is expected on October 1. Blocked funds for unsuccessful applications should be released, and allotted shares credited to demat accounts, before listing, expected on October 5. On listing day, a special pre-open session on the exchanges discovers the opening price, and normal trading in the new shares begins at 10 am. You can check allotment status on the registrar's website: KFin Technologies for SRIT India and MUFG Intime for Shah Investor's Home.
6. What are the key business differences between the two companies?
SRIT India is an IT and IT-enabled services company based in Bengaluru. It builds and operates digital platforms for government health departments, e-governance programmes and telecom clients, and reports a Rs 1,204.7 crore order book. Shah Investor's Home is a Gujarat-based retail stockbroker founded in 1994. It earns from equity and derivatives broking, IPO applications, mutual fund distribution and margin trading funding. Despite its name, it has no real estate business. The practical difference is how revenue behaves: SRIT's income follows multi-year contracts, while Shah's rises and falls with stock market trading volumes and regulatory changes.
7. What risks should I consider before investing in these IPOs?
GMP can fall before listing, and listing gains are never assured. For SRIT India, the main risks are dependence on government clients, slow payment cycles that tie up working capital, and execution risk on large public projects. For Shah Investor's Home, the main risks are falling earnings (FY26 profit down 44%), sensitivity to market trading volumes, SEBI rule changes on derivatives trading, credit risk in its margin funding book, and concentration in Gujarat and Mumbai. For both, a weak market during listing week can push shares below the issue price regardless of company quality.
8. How do the financial margins compare between the two companies?
Shah Investor's Home has higher margins, but SRIT India has stronger growth. In FY26, Shah's EBITDA margin was about 29.8% and its profit after tax (PAT) margin about 18.1%. SRIT's EBITDA margin was 14.39% and its PAT margin 9.62%. EBITDA margin shows how much of each rupee of revenue the core business keeps before interest, tax and depreciation; PAT margin shows what is left for shareholders. Broking is a naturally high-margin, low-cost model, while IT project delivery carries higher staff and execution costs. The market is weighing direction over level: SRIT's profit grew 29% while Shah's fell 44%.
9. Are the estimated listing prices guaranteed?
No. The estimated listing prices of Rs 161 for SRIT India and Rs 182 for Shah Investor's Home are derived from grey market premiums, which are informal and unregulated. The actual listing price was discovered on October 6 through a special pre-open session on NSE and BSE, based on real buy and sell orders. It can land above, at or below the GMP estimate, and even below the issue price. IPOs with strong GMPs have listed flat or at a discount in the past when markets fell during listing week. Treat the estimate as one data point, not a promise.
10. Which IPO is better for a first-time retail investor?
It depends on your goal. If the aim is a listing-day gain, SRIT India shows the stronger signal on current data: a higher GMP, retail subscription of 6.04 times, rising profit and a lower valuation. The trade-off is that heavy oversubscription reduces your chance of allotment. If the aim is long-term holding, read each company's red herring prospectus first, especially the risk factors and cash flow sections. Apply only with money you can afford to see fall in value, and decide your exit plan before listing day. This is educational information, not a recommendation to buy or sell.
Disclaimer
This article is for educational purposes only and does not constitute investment advice or a recommendation to buy, sell or hold any security. Grey market premium figures are unofficial and change frequently. IPO investments are subject to market risk. Read the red herring prospectus carefully and consult a SEBI-registered investment adviser before making investment decisions.
